Impact of loco-regional treatment on metastatic breast cancer outcome: a review

W Khodari, A Sedrati, I Naisse, R Bosc… - Critical Reviews in …, 2013 - Elsevier
Metastatic breast cancer (MBC) at presentation (Stage IV) is a devastating diagnosis with a
poor prognosis and a 5-year overall survival rate not exceeding 20%. The treatment is …
被引用次数：34 相关文章

[引用][C] Impact of loco-regional treatment on metastatic breast cancer outcome: A review

W Khodari, A Sedrati, I Naisse, R Bosc… - Critical Reviews in …, 2013 - cir.nii.ac.jp
Impact of loco-regional treatment on metastatic breast cancer outcome: A review | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲ恁[サイニィ] 詳細へ移動 検索フォ恁啶 …

Impact of loco-regional treatment on metastatic breast cancer outcome: A review

W Khodari, A Sedrati, I Naisse, R Bosc… - Critical Reviews in …, 2013 - infona.pl
Metastatic breast cancer (MBC) at presentation (Stage IV) is a devastating diagnosis with a
poor prognosis and a 5-year overall survival rate not exceeding 20%. The treatment is …

Impact of loco-regional treatment on metastatic breast cancer outcome: a review.

W Khodari, A Sedrati, I Naisse, R Bosc… - Critical Reviews in …, 2013 - europepmc.org
Metastatic breast cancer (MBC) at presentation (Stage IV) is a devastating diagnosis with a
poor prognosis and a 5-year overall survival rate not exceeding 20%. The treatment is …

Impact of loco-regional treatment on metastatic breast cancer outcome: a review

W Khodari, A Sedrati, I Naisse… - Critical reviews in …, 2013 - pubmed.ncbi.nlm.nih.gov
Metastatic breast cancer (MBC) at presentation (Stage IV) is a devastating diagnosis with a
poor prognosis and a 5-year overall survival rate not exceeding 20%. The treatment is …